United American Healthcare (OTCMKTS:UAHC) versus ClearPoint Neuro (NASDAQ:CLPT) Head to Head Analysis

United American Healthcare (OTCMKTS:UAHC) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations.

Earnings & Valuation

This table compares United American Healthcare and ClearPoint Neuro’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United American Healthcare	N/A	N/A	N/A	N/A	N/A
ClearPoint Neuro	$23.95 million	6.01	-$22.09 million	($0.91)	-5.85

United American Healthcare has higher earnings, but lower revenue than ClearPoint Neuro.

Profitability

This table compares United American Healthcare and ClearPoint Neuro’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
United American Healthcare	N/A	N/A	N/A
ClearPoint Neuro	-92.21%	-83.94%	-47.92%

Analyst Ratings

This is a breakdown of recent ratings and price targets for United American Healthcare and ClearPoint Neuro, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United American Healthcare	0	0	0	0	N/A
ClearPoint Neuro	0	0	3	0	3.00

ClearPoint Neuro has a consensus target price of $12.00, indicating a potential upside of 125.56%. Given ClearPoint Neuro’s higher probable upside, analysts clearly believe ClearPoint Neuro is more favorable than United American Healthcare.

Insider and Institutional Ownership

30.1% of ClearPoint Neuro shares are held by institutional investors. 14.3% of United American Healthcare shares are held by insiders. Comparatively, 6.1% of ClearPoint Neuro shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

United American Healthcare has a beta of -1.42, indicating that its share price is 242% less volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500.

Summary

ClearPoint Neuro beats United American Healthcare on 5 of the 9 factors compared between the two stocks.

About United American Healthcare

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.

About ClearPoint Neuro

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.